Fundamental Data for ELN

ELAN CP PL(NYSE:ELN)

Elan Corporation, plc is a leading worldwide specialty pharmaceutical company focused on the discovery, development and marketing of therapeutic products and services in neurology, acute care and pain management and on the development and commercialization of products using its extensive range of proprietary drug delivery technologies. The company consists of three operating divisions: Elan Pharmaceuticals, Elan Pharmaceutical Technologies and Elan Pharmaceutical Operations.

# Employees: 1610

Address: ,,,

Phone:

Fax:

Website:

Email:

Sector: Medical

Industry: MED-DRUGS

Executive Officers

No Information

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 2/8/2010

Mean EPS (Next Qtr): ($0.09)

Mean EPS (Year): ($0.46)

Mean Estimate(Long Term): ($0.01)

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 4

Shares Performance

Period	ELN	Compare to S&P
YTD	7.67 %	-10.89 %
4 Weeks	21.66 %	20.34 %
12 Weeks	-12.94 %	-17.92 %

Shares Information

Analyst Coverage: Y

Avg Volume: 6440508

Shares Outstanding: 475M

Market Cap: $3.07B

52 Week High: $8.70

52 Week Low: $5.00

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 6/7/1999 ELN split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: 50.00 %

EPS Growth in Last Year: 66.67 %

Sales Growth in Last Quarter: 2.17 %

Sales Growth in Last Quarter: 6.26 %

Financials

Qtr Book Value: $5.58

Cash Flow/Share: ($0.01)

Change in Payout Ratio: -0.010

Price/Sales: 2.840